
LogicBio Therapeutics LOGC
LogicBio Therapeutics Long Term Debt Current | LOGC
Annual Long Term Debt Current LogicBio Therapeutics
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.23 M | 1.09 M | 504 K | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.23 M | 504 K | 942 K |
Long Term Debt Current of other stocks in the Biotechnology industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Annexon
ANNX
|
2.91 M | $ 3.11 | -8.94 % | $ 482 M | ||
|
Acasti Pharma
ACST
|
75 K | - | 4.01 % | $ 150 M | ||
|
Aptose Biosciences
APTO
|
193 K | - | -45.71 % | $ 1.2 M | ||
|
Galapagos NV
GLPG
|
1.73 M | - | - | $ 1.83 B | ||
|
Achieve Life Sciences
ACHV
|
61 K | $ 6.78 | 0.89 % | $ 296 M | ||
|
Leap Therapeutics
LPTX
|
38 K | - | 368.57 % | $ 41.9 M | ||
|
Lumos Pharma
LUMO
|
282 K | - | - | $ 35.3 M | ||
|
Gamida Cell Ltd.
GMDA
|
1.87 M | - | -18.25 % | $ 5.04 M | ||
|
Axcella Health
AXLA
|
1.59 M | - | -16.42 % | $ 249 M | ||
|
Metacrine
MTCR
|
825 K | - | - | $ 24.2 M | ||
|
Zealand Pharma A/S
ZEAL
|
14.9 M | - | 0.52 % | $ 821 M | ||
|
Myovant Sciences Ltd.
MYOV
|
2.15 M | - | -0.04 % | $ 2.62 B | ||
|
Bellerophon Therapeutics
BLPH
|
203 K | - | -74.18 % | $ 955 K | ||
|
Idera Pharmaceuticals
IDRA
|
234 K | - | -23.04 % | $ 26.6 M | ||
|
Verona Pharma plc
VRNA
|
1.12 M | - | - | $ 69.7 B | ||
|
Atreca
BCEL
|
3.54 M | - | -11.76 % | $ 5.79 M | ||
|
Guardion Health Sciences
GHSI
|
3.81 K | - | -0.31 % | $ 3.64 M | ||
|
Opiant Pharmaceuticals
OPNT
|
338 K | - | - | $ 109 M | ||
|
Akouos
AKUS
|
671 K | - | 0.23 % | $ 488 M | ||
|
ImmunoGen
IMGN
|
4.1 M | - | - | $ 7.92 B | ||
|
Vascular Biogenics Ltd.
VBLT
|
445 K | - | -8.77 % | $ 12.4 M | ||
|
Cidara Therapeutics
CDTX
|
1.38 M | - | - | $ 1.41 B | ||
|
Iterum Therapeutics
ITRM
|
67 K | - | - | $ 591 K | ||
|
Navidea Biopharmaceuticals
NAVB
|
19 K | - | -2.99 % | $ 2.47 M | ||
|
Stealth BioTherapeutics Corp
MITO
|
9 M | - | - | $ 23.9 M | ||
|
OncoSec Medical Incorporated
ONCS
|
1.11 M | - | 31.87 % | $ 1.61 M | ||
|
BioDelivery Sciences International
BDSI
|
336 K | - | -4.8 % | $ 255 M | ||
|
Albireo Pharma
ALBO
|
1.4 M | - | -0.23 % | $ 916 M | ||
|
bluebird bio
BLUE
|
25.1 M | - | - | $ 546 M | ||
|
CASI Pharmaceuticals
CASI
|
868 K | - | - | $ 35.4 M | ||
|
ContraFect Corporation
CFRX
|
671 K | - | -5.16 % | $ 5.39 M | ||
|
Sigilon Therapeutics
SGTX
|
4.48 M | - | - | $ 728 M | ||
|
Regulus Therapeutics
RGLS
|
781 K | - | - | $ 155 M | ||
|
NGM Biopharmaceuticals
NGM
|
5.38 M | - | - | $ 127 M | ||
|
Aravive
ARAV
|
2.2 M | - | -13.39 % | $ 1.45 M | ||
|
Crinetics Pharmaceuticals
CRNX
|
6.49 M | $ 84.95 | 0.13 % | $ 7.99 B | ||
|
Acer Therapeutics
ACER
|
104 K | - | 2.71 % | $ 14 M | ||
|
Gilead Sciences
GILD
|
102 M | $ 166.01 | -0.31 % | $ 207 B | ||
|
Assembly Biosciences
ASMB
|
569 K | $ 22.14 | -1.6 % | $ 248 M | ||
|
Dynavax Technologies Corporation
DVAX
|
4.18 M | - | - | $ 2.02 B | ||
|
Turning Point Therapeutics
TPTX
|
3.63 M | - | -0.13 % | $ 3.73 B | ||
|
Orgenesis
ORGS
|
234 K | - | -33.86 % | $ 61.2 M | ||
|
TCR2 Therapeutics
TCRR
|
21.8 M | - | - | $ 58.1 M |